[PDF] Top 20 Overview of the use of recombinant factor VIIa in children

... treat children with abnormal bleed- ing for approximately 25 ...treat children with hemophilia and inhibitors, rFVIIa has been shown to be very effective at controlling bleeding, with an excellent safety ... See full document

... nonhemophiliac children. Off-label rFVIIa use in children with DIC and MODS may be futile, and the use of PRISM score combined with other clinical variables, such as presence of organ failure, ... See full document

... The Children ’ s Hospital at Westmead, Concord Hospital, John Hunter Hospital, Liverpool Hospital, Prince of Wales Hospital, St Vincent ’ s Hospital, Sydney Children ’ s Hospital; Northern Territory: Alice ... See full document

... successful use of intrapulmonary rFVIIa for ...tissue factor in the alveoli causing balanced and durable hemostases with improvement in oxygen transport ... See full document

... of factor VIII or IX and on liver transplant patients suffering from a very complex ...to use immediately and therefore not suitable for use outside research ... See full document

... prophylactic use of rFVIIa in a group of patients undergoing semielective open reduction on traumatic pelvic and pelvic acetabular ...prophylactic use of rFVIIa was not justified in fit healthy patients, ... See full document

... rFVIIa use in wICH, the thromboembolic risks of PCC use in this population is still ...activated factor capable of direct binding to tissue factor suggest it may achieve faster hemostasis, PCC ... See full document

... rFVIIa use for patients with ECMO with intractable bleeding was associated with bleeding control and decreased blood-product ...its use should be considered, and clinicians should be aware of the risk of ... See full document

... for use of rFVIIa included acute post-traumatic hemorrhage, severe traumatic brain injury, septic coagulopathy, and factor ...the use of rFVIIa in similar patients, but often these patients have been ... See full document

... in children with DAH or IPH and further the risk of acquiring irreversible pulmonary fibrosis due to insufficient iron clearance, a trial with inhaled FVIIa seems to be far less risky in spite of such an ... See full document

... off-label use are ...off-label use of rFVIIa could result in more side effects than could be expected from the literature because of a publication ...off-label use of rFVIIa are urgently needed but ... See full document

... 4 factor PCC product available in Europe has completed clinical trials and has recently been ap- proved by the FDA (Kcentra®) for warfarin reversal in patients with acute major ...4 factor PCC product was ... See full document

... and independent studies, rFVIIa at the dose of 90 µ g/kg appears to be the standard dose commonly used among patients. A 2-hour interval is applied for the first 24 to 48 hours and thereafter increases to 3 to 6 hours ... See full document

... coagulation factor concentrates ineffective, and alternative means must be used to achieve ...hemostasis. Recombinant factor VIIa (rFVIIa) was developed to control bleed- ing episodes in ... See full document

... the use of rFVIIa in life threatening PPH was carried out by Franchini et ...the use of factor VIIa reduced the rate of hysterectomy, as in many cases this had been performed before ... See full document

... the use of rFVIIa in Australia and New Zealand which reports on the outcomes of 2181 trauma cases, the single most important predictor of the effect of rFVIIa on bleeding and 28-day mortality was pH ...rFVIIa ... See full document

... The adverse event of greatest significance noted in the Phase II trial was the increased risk of arterial thromboem- bolism. We made the assumption that 50% of these ATE events were ischemic strokes (IS) and 50% were ... See full document

... activated factor VIIa (FVIIa), a coagulation factor circulating at low levels within the blood- stream, the so-formed TF/FVII complex initiates the extrinsic coagulation pathway; the TF/FVIIa complex ... See full document

... Certainty Factor (CF) method by consulting can answer each question with yes or no, in order to find out information about the symptoms and problems of existing technostress and the solution to therapy for these ... See full document

... Dumai is one of the regencies/cities in Province Riau that has become City and secede from Sub Bengkalis since 1999. In 2013 , the poverty rate in Dumai by 4,83 % , then increased to 5.2 6 % in 2014 (Census year 2014). ... See full document